Thalys Medical Technology Group Corporation (SHA:603716)

SHA:603716 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,714	1,350	2,126	2,115	2,800	3,265
Market Cap Growth	25.85%	-36.50%	0.51%	-24.45%	-14.23%	-5.78%
Enterprise Value	6,419	2,305	3,163	3,337	3,959	4,036
Last Close Price	30.55	7.22	11.09	11.04	14.39	16.47
PE Ratio	-	-	-	-	-	56.72
Forward PE	-	35.82	35.82	35.82	35.82	35.82
PS Ratio	3.54	0.75	1.06	0.92	1.08	1.54
PB Ratio	6.07	1.40	1.62	1.41	1.61	1.81
P/TBV Ratio	6.76	1.57	2.00	1.72	2.04	2.24
P/FCF Ratio	103.03	17.68	25.00	-	-	-
P/OCF Ratio	75.07	13.56	16.89	75.23	-	328.31
EV/Sales Ratio	3.98	1.27	1.58	1.45	1.52	1.90
EV/EBITDA Ratio	-	48.74	94.19	73.79	23.73	16.09
EV/EBIT Ratio	-	179.00	-	-	41.75	23.15
EV/FCF Ratio	115.74	30.18	37.19	-	-	-
Debt / Equity Ratio	0.90	0.96	0.80	0.94	0.92	0.78
Debt / EBITDA Ratio	60.54	14.48	18.82	20.41	8.37	5.57
Debt / FCF Ratio	15.34	12.11	12.34	-	-	-
Asset Turnover	0.58	0.59	0.55	0.56	0.63	0.62
Inventory Turnover	4.09	4.44	4.24	4.21	4.75	4.36
Quick Ratio	1.49	1.23	1.42	1.32	1.53	1.75
Current Ratio	1.93	1.52	1.72	1.61	1.87	2.11
Return on Equity (ROE)	-19.44%	-16.99%	-11.15%	-11.74%	-2.17%	4.79%
Return on Assets (ROA)	-0.73%	0.26%	-0.32%	-0.24%	1.44%	3.15%
Return on Capital (ROIC)	-0.97%	0.38%	-0.45%	-0.31%	1.81%	3.84%
Return on Capital Employed (ROCE)	-	0.90%	-	-	3.70%	6.90%
Earnings Yield	-3.97%	-15.50%	-7.46%	-7.27%	-1.77%	1.76%
FCF Yield	0.97%	5.66%	4.00%	-1.25%	-6.92%	-3.61%
Payout Ratio	-	-	-	-	-	103.03%
Buyback Yield / Dilution	-13.39%	0.73%	0.62%	1.73%	0.23%	-0.66%
Total Shareholder Return	-	0.73%	0.62%	1.73%	0.23%	-0.66%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.